Comprehensive analysis of SARS‐CoV‐2 antibody dynamics in New Zealand

Abstract

Antibodies to SARS-CoV-2 persist for up to 8 months following mild-to-moderate infection. This robust response can be attributed to the initial exposure without immune boosting given the lack of community transmission in our setting.